SAGE THERAPEUTICS, INC.

(SAGE)
  Report
Delayed Nasdaq  -  03:46 2022-08-18 pm EDT
42.71 USD   -0.95%
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Rating
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SAGE THERAPEUTICS, INC.
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ra..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Ratin..
MT
08/02TRANSCRIPT : Sage Therapeutics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02Sage Therapeutics Widens Q2 Net Loss as Revenue Declines
MT
08/02Sage Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months ..
CI
08/02SAGE THERAPEUTICS : Announces Second Quarter 2022 Financial Results and Highlights Pipelin..
PU
08/02Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeli..
BU
08/01Sage Therapeutics to Present at Upcoming August Investor Conferences
BU
07/19Sage Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 2,..
BU
07/14SAGE THERAPEUTICS : IF YOU DO NOT OBJECT TO THE PROPOSED SETTLEMENT, OR THE AGREED-TO ATTO..
PU
07/11SVB Securities Adjusts Sage Therapeutics' Price Target to $40 from $50, Keeps Market Pe..
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcar..
MT
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 1000 Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 1000 Dynamic Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) added to Russell 2000 Dynamic Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) added to Russell 2000 Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell Midcap Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) added to Russell 2000 Value Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 1000 Value Index
CI
06/24SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell Midcap Value Index
CI
06/13TRANSCRIPT : Sage Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthca..
CI
06/13Sage Therapeutics, Inc. Provides Zuranolone New Drug Application Update
CI
06/08TRANSCRIPT : Sage Therapeutics, Inc. Presents at 2022 Jefferies Global Healthcare Conferen..
CI
06/02RBC Capital Adjusts Price Target for Sage Therapeutics to $37 From $35, Maintains Secto..
MT
06/02Sage Therapeutics to Present at Upcoming June Investor Conferences
BU
06/01WALL STREET STOCK EXCHANGE : Wall Street starts a new chapter
MS
06/01TRANSCRIPT : Sage Therapeutics, Inc. - Special Call
CI
06/01SAGE THERAPEUTICS : and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Po..
PU
06/01Sage Therapeutics, Biogen Say Phase 3 Study of Postpartum Depression Treatment Met Prim..
MT
06/01Sage-Biogen drug improves symptoms in postpartum depression study
RE
06/01Sage, Biogen's drug meets main goal in postpartum depression study
RE
06/01Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in P..
BU
06/01SAGE, BIOGEN : Zuranolone Hits Key Goals in Postpartum Depression
DJ
05/24Goldman Sachs Lowers Sage Therapeutics' Price Target to $73 From $85, Maintains Buy Rat..
MT
05/11TRANSCRIPT : Sage Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conferenc..
CI
05/10Morgan Stanley Adjusts Sage Therapeutics' Price Target to $53 from $57, Keeps Equalweig..
MT
05/09INSIDER BUY : Sage Therapeutics
MT
05/04Mizuho Securities Adjusts Sage Therapeutics' Price Target to $37 From $41, Maintains Ne..
MT
05/04RBC Cuts Price Target on Sage Therapeutics to $35 From $37, Citing Cash Burn Guidance, ..
MT
05/04Sage Therapeutics to Present at Bank of America Securities 2022 Healthcare Conference
BU
05/03Wedbush Lowers Price Target for Sage Therapeutics to $54 From $75, Maintains Outperform..
MT
05/03TRANSCRIPT : Sage Therapeutics, Inc., Q1 2022 Earnings Call, May 03, 2022
CI
05/03Sage Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
CI
05/03Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipelin..
BU
05/03Sage Therapeutics Appoints Mark Pollack as Senior Vice President, Medical Affairs
CI
05/02Sage, Biogen Start Rolling Submission of New-Drug Application to US FDA for Major Depre..
MT
05/02Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) ..
BU
04/19Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 202..
BU
04/04CORRECTION : Sector Update: Health Care Stocks Advance Pre-Bell Friday
MT
04/04CORRECTION : Sector Update: Health Care
MT
04/04CORRECTION : Sector Update: Health Care Stocks Finishing Near Friday Session Highs
MT
04/04CORRECTION : Sage Therapeutics Reports 'Promising' Results in Study of Treatment for Mild ..
MT
04/04Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 LUMINARY..
AQ
04/01SECTOR UPDATE : Health Care Stocks Finishing Near Friday Session Highs
MT
04/01SECTOR UPDATE : Health Care
MT
04/01SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Friday
MT
04/01Sage Therapeutics Reports 'Promising' Results in Study of Treatment for Mild Dementia D..
MT
04/01Wall Street Leans Forward Pre-Bell; Futures Green, Europe Up, Asia Choppy
MT
04/01Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 LUMINARY..
BU
04/01Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 Luminary..
CI
03/31Berenberg Bank Initiates Sage Therapeutics at Hold With $37 Price Target
MT
03/29TRANSCRIPT : Sage Therapeutics, Inc. Presents at Stifel CNS Days, Mar-29-2022 04:00 PM
CI
03/22Sage Therapeutics to Present at 2022 Stifel CNS Days
BU
03/15Sage Therapeutics' Treatment for Parkinson's-related Cognitive Deficit Improves Patient..
MT
03/15Sage Therapeutics Announces Presentation of Encouraging Results from the Phase 2 PARADI..
BU
03/10Morgan Stanley Adjusts Sage Therapeutics' Price Target to $57 from $61, Keeps Equalweig..
MT
03/07TRANSCRIPT : Sage Therapeutics, Inc. Presents at 42nd Annual Cowen Health Care Conference,..
CI
03/03Mizuho Securities Adjusts Sage Therapeutics' Price Target to $41 From $44, Maintains Ne..
MT
02/28Sage Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference
BU
02/25Stifel Nicolaus Lower Price Target for Sage Therapeutics to $58 From $75, Maintains Buy..
MT
02/25Goldman Sachs Lowers Sage Therapeutics' Price Target to $85 From $96, Maintains Buy Rat..
MT
02/25Canaccord Genuity Lowers Price Target for Sage Therapeutics to $64 From $96, Maintains ..
MT
02/25SVB Leerink Lowers Sage Therapeutics Price Target to $50 From $60, Maintains Market Per..
MT
02/25Wedbush Cuts Price Target on Sage Therapeutics to $75 From $79, Citing Lower Zulresso E..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SAGE THERAPEUTICS, INC.